Veracyte VCYT Stock
$48.69
1.861923%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$3.89B
LOW - HIGH [24H]
$46.49
-
$49.40
VOLUME [24H]
$1.45M
P/E Ratio
45.08
Earnings per share
$1.08
ISIN
US92337F1075
Veracyte Price Chart
Veracyte VCYT Financial and Trading Overview
| Veracyte stock price | 48.69 USD |
| Previous Close | 46.34 USD |
| Open | 46.14 USD |
| Bid | 35.2 USD x 200 |
| Ask | 58.81 USD x 200 |
| Day's Range | 45.27 - 49.25 USD |
| 52 Week Range | 22.61 - 50.71 USD |
| Volume | 1.47M USD |
| Avg. Volume | 982.61K USD |
| Market Cap | 3.84B USD |
| Beta (5Y Monthly) | 1.885 |
| PE Ratio (TTM) | 44.61111 |
| EPS (TTM) | 1.08 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 47.4 USD |
VCYT Valuation Measures
| Enterprise Value | 3.3B USD |
| Trailing P/E | 44.61111 |
| Forward P/E | 25.29134 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.096372 |
| Price/Book (mrq) | 2.919646 |
| Enterprise Value/Revenue | 6.088 |
| Enterprise Value/EBITDA | 31.646 |
Trading Information
Veracyte Stock Price History
| Beta (5Y Monthly) | 1.885 |
| 52-Week Change | 73.29% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 50.71 USD |
| 52 Week Low | 22.61 USD |
| 50-Day Moving Average | 35.99 USD |
| 200-Day Moving Average | 37.09 USD |
VCYT Share Statistics
| Avg. Volume (3 month) | 982.61K USD |
| Avg. Daily Volume (10-Days) | 1.13M USD |
| Shares Outstanding | 79.79M |
| Float | 79.36M |
| Short Ratio | 8.94 |
| % Held by Insiders | 0.50% |
| % Held by Institutions | 113.29% |
| Shares Short | 8.59M |
| Short % of Float | 12.74% |
| Short % of Shares Outstanding | 10.77% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 16.24% |
| Operating Margin (ttm) | 16.28% |
| Gross Margin | 72.90% |
| EBITDA Margin | 19.23% |
Management Effectiveness
| Return on Assets (ttm) | 3.75% |
| Return on Equity (ttm) | 6.93% |
Income Statement
| Revenue (ttm) | 541.74M USD |
| Revenue Per Share (ttm) | 6.86 USD |
| Quarterly Revenue Growth (yoy) | 21.50% |
| Gross Profit (ttm) | 394.97M USD |
| EBITDA | 104.21M USD |
| Net Income Avi to Common (ttm) | 88.01M USD |
| Diluted EPS (ttm) | 1.08 |
| Quarterly Earnings Growth (yoy) | 307.39% |
Balance Sheet
| Total Cash (mrq) | 439.06M USD |
| Total Cash Per Share (mrq) | 5.5 USD |
| Total Debt (mrq) | 39.33M USD |
| Total Debt/Equity (mrq) | 2.93 USD |
| Current Ratio (mrq) | 9.305 |
| Book Value Per Share (mrq) | 16.502 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 166.16M USD |
| Levered Free Cash Flow (ttm) | 104.51M USD |
Profile of Veracyte
| Country | United States |
| State | CA |
| City | South San Francisco |
| Address | 6000 Shoreline Court |
| ZIP | 94080 |
| Phone | 650 243 6300 |
| Website | https://www.veracyte.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 755 |
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Q&A For Veracyte Stock
What is a current VCYT stock price?
Veracyte VCYT stock price today per share is 48.69 USD.
How to purchase Veracyte stock?
You can buy VCYT shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Veracyte?
The stock symbol or ticker of Veracyte is VCYT.
Which industry does the Veracyte company belong to?
The Veracyte industry is Diagnostics & Research.
How many shares does Veracyte have in circulation?
The max supply of Veracyte shares is 79.79M.
What is Veracyte Price to Earnings Ratio (PE Ratio)?
Veracyte PE Ratio is 45.08333200 now.
What was Veracyte earnings per share over the trailing 12 months (TTM)?
Veracyte EPS is 1.08 USD over the trailing 12 months.
Which sector does the Veracyte company belong to?
The Veracyte sector is Healthcare.
Veracyte VCYT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Composite Total Return XCMP | 33104.2 USD — |
-0.89
|
— — | 32999.64 USD — | 33445.55 USD — | — - | — — |
| US Tech US 700 Small Cap Value I NQUS700SCV | 2597.93 USD — |
-1.42
|
— — | 2596.87 USD — | 2622.13 USD — | — - | — — |
| US Tech Global Market Composite NQGM | 2296 USD — |
-1.38
|
— — | 2280.64 USD — | 2323.09 USD — | — - | — — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| US Tech US 700 Small Cap Value N NQUS700SCVN | 2971.86 USD — |
-1.42
|
— — | 2970.65 USD — | 2999.54 USD — | — - | — — |
| US Tech US 700 Small Cap Index NQUS700SC | 2992.49 USD — |
-1.38
|
— — | 2986.86 USD — | 3018.97 USD — | — - | — — |
| US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG | 4054.02 USD — |
-0.25
|
— — | 4019.75 USD — | 4077 USD — | — - | — — |
| US Tech Biotechnology NBI | 5807.22 USD — |
+1.87
|
— — | 5685.34 USD — | 5809.82 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}